MW
Mark Wilterding
DELAYED 1 MONTH
Chief Financial Officer
RxSight, Inc.
Filings
1
Companies
1
Latest
Feb 28, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
RxSight, Inc.
Mark Wilterding
Chief Financial Officer
Option Exercise
—
20,441 sh
Mar 4 1:24 AM
Feb 28, 2026